We are live on ! Find out more
ONCE

Spark Therapeutics, Inc. Common Stock
ONCE

Delisted

ONCE was delisted on the 16th of December, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Spark Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 183 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 184 → 0 (-184)

100% less funds holding in top 10

Funds holding in top 10: 23 → 0 (-23)

100% less capital invested

Capital invested by funds: $3.44B → $0 (-$3.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 183

Holders
–
Holders Change
-184
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-23
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
183
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$314M
2
BlackRock
BlackRock
New York
-$278M
3
PCM
Pentwater Capital Management
Florida
-$204M
4
BC
Boxer Capital
California
-$160M
5
PC
Paulson & Co
New York
-$139M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
76
California Public Employees Retirement System
California
– -$7.77M -80,144 Closed
QOP
77
Quinn Opportunity Partners
Virginia
– -$7.5M -77,347 Closed
BFM
78
Boothbay Fund Management
New York
– -$7.42M -76,557 Closed
Swiss National Bank
79
Swiss National Bank
Switzerland
– -$6.78M -69,900 Closed
SAM
80
Silphium Asset Management
United Kingdom
– -$6.73M -69,399 Closed
FFH
81
Fairfax Financial Holdings
Ontario, Canada
– -$6.54M -67,400 Closed
California State Teachers Retirement System (CalSTRS)
82
California State Teachers Retirement System (CalSTRS)
California
– -$6.17M -63,631 Closed
Rafferty Asset Management
83
Rafferty Asset Management
New York
– -$6M -61,872 Closed
Capstone Investment Advisors
84
Capstone Investment Advisors
New York
– -$5.18M -53,374 Closed
EMPI
85
Elo Mutual Pension Insurance
Finland
– -$5.14M -53,000 Closed
N
86
Natixis
France
– -$4.75M -48,956 Closed
OGC
87
One68 Global Capital
New York
– -$4.66M -48,066 Closed
RhumbLine Advisers
88
RhumbLine Advisers
Massachusetts
– -$4.57M -47,081 Closed
QCMA
89
Quad Capital Management Advisors
New York
– -$4.09M -42,191 Closed
BPGAM
90
BTG Pactual Global Asset Management
Bermuda
– -$4.07M -42,005 Closed
Skandinaviska Enskilda Banken (SEB)
91
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$3.88M -40,000 Closed
LM
92
Litespeed Management
New York
– -$3.54M -36,500 Closed
New York State Common Retirement Fund
93
New York State Common Retirement Fund
New York
– -$3.5M -36,100 Closed
Royal Bank of Canada
94
Royal Bank of Canada
Ontario, Canada
– -$3.48M -35,847 Closed
GC
95
Guggenheim Capital
Illinois
– -$3.33M -34,298 Closed
Citigroup
96
Citigroup
New York
– -$3.27M -33,672 Closed
UBS AM
97
UBS AM
Illinois
– -$3.26M -33,590 Closed
Walleye Trading
98
Walleye Trading
New York
– -$3.23M -33,309 Closed
AQR Capital Management
99
AQR Capital Management
Connecticut
– -$3.19M -32,848 Closed
Susquehanna International Group
100
Susquehanna International Group
Pennsylvania
– -$2.85M -29,421 Closed
2 3
4
5 6

ONCE Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spark Therapeutics, Inc. Common Stock (ONCE) for Q4 2019, worth a combined $0 — down 100% from $3.44B a quarter earlier.

Sellers outnumbered buyers: 183 funds closed out of ONCE and 0 opened new positions — a net loss of 183 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $314M sold.

  • 0 institutional investors held Spark Therapeutics, Inc. Common Stock (ONCE) as of Q4 2019, down from 184 in Q3 2019.
  • Funds reported $0 of Spark Therapeutics, Inc. Common Stock stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Spark Therapeutics, Inc. Common Stock positions in Q4 2019 and 183 closed out, a net change of -183 holders.
  • The largest Spark Therapeutics, Inc. Common Stock seller in Q4 2019 was Vanguard Group, an estimated $314M sold.

Based on aggregated 13F filings for Q4 2019.